It could be concluded that when Linagliptin when added to subjects with T2 DMand CKD, along with metformin and/or Insulin, demonstrates a functional improvement of CD34+ Endothelial Progenitor Cell migratory function through increased CD34/CXCR4 positivity. This evidence concerns the gene INS and chronic kidney disease.